Amniotic Membrane or amnion refers to the innermost layer of the placenta. It acts as a physical barrier between the fetus and the mother's uterus. Amniotic membrane finds wide application in wound healing and surgical reconstruction owing to its anti-inflammatory, anti-scarring, and anti-angiogenic properties. It is used in treatments involving burns, skin injuries, ophthalmic defects, and chronic non-healing ulcers. The growing geriatric population suffering from chronic diseases and wounds has increased the demand for amniotic membrane products in wound management.
The Global Amniotic Membrane Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the Amniotic Membrane market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. The growing aging population and increase in chronic wounds has augmented the demand for amniotic membrane products. Technological advancements such as development of micronized and acellular amniotic membranes formulations have expanded the application scope of amniotic membranes.
Market Trends
Cryopreservation of Amniotic Membranes - Cryopreservation allows for long-term storage of amniotic membranes at sub-zero temperatures while maintaining viability and key properties. This enables stockpiling and just-in-time delivery of amniotic membranes to clinics and hospitals. Micronization of Amniotic Membranes - Micronization is the process of comminuting amniotic membranes into micron-sized powder. This improves handling, storage, and delivers concentrated growth factors effectively to target sites. Micronized amniotic membranes have applications in wound healing and regenerative medicine.
Market Opportunities
Rising Aging Population - The growing geriatric population prone to chronic wounds, burns, and non-healing injuries will drive the demand for amniotic membrane products in wound management over the forecast period. Expanding Applications in Regenerative Medicine - Increased research on regenerative potential of amniotic membranes is extending their use in treatment of degenerative ocular surface diseases, lower urinary tract conditions, musculoskeletal disorders thereby opening new opportunities.
Impact of COVID-19 on Amniotic Membrane Market:
The COVID-19 pandemic posed significant challenges to the amniotic membrane market. During the early phases of the pandemic, restrictions on non-essential medical procedures led to supply chain disruptions and uncertainties around product availability. Manufacturers faced challenges in sourcing raw materials and maintaining continuous production due to lockdowns and social distancing measures. Movement restrictions also impacted the delivery of products to customers. The focus of healthcare resources on critical COVID-19 patients resulted in delays and postponements of other medical procedures that utilize amniotic membrane products. This adversely affected market demand in the short term.
However, as the pandemic progressed, manufacturers were able to adjust production strategies to meet essential demand. Supply chains also stabilized with adaptations like enhancing inventory levels, diversifying sourcing, and prioritizing critical shipments. Telehealth emerged as an important tool to provide care for non-critical cases. This helped sustain consistent demand for amniotic membrane products in wound care and ocular surface applications. Research activities into the wound healing and anti-inflammatory properties of amniotic membranes also received increased attention for their potential in treating COVID-19 induced conditions like lung fibrosis. The long term market forecast remains positive, bolstered by the backlog in procedures postponed during the peak pandemic phases and ongoing R&D efforts exploring new therapeutic use cases.
North America currently accounts for the largest share of the global amniotic membrane market in terms of revenue. This is attributed to factors such as the rising prevalence of target diseases, growing geriatric population susceptible to chronic wounds, strong reimbursement structure, and technological advancements in wound care management. Within the region, the United States holds the major market share and is expected to experience steady growth over the forecast period due to the high accessibility to advanced treatments.
Asia Pacific is poised to be the fastest-growing regional market for amniotic membranes from 2023 to 2030. This can be credited to increasing medical expenditures, growing public awareness about advanced wound care options, and rising medical tourism in the region. Further boosting regional market growth is the large patient pool affected by burns, chronic wounds, and ocular surface ailments.
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/
